Compugen Ltd (NAS:CGEN)
$ 2.01 -0.08 (-3.83%) Market Cap: 187.53 Mil Enterprise Value: 138.20 Mil PE Ratio: 0 PB Ratio: 2.85 GF Score: 51/100

Q4 2020 Compugen Ltd Earnings Call Transcript

Feb 25, 2021 / 01:30PM GMT
Release Date Price: $8.96 (-13.51%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Compugen's Fourth Quarter and Full Year 2020 Results Conference Call. (Operator Instructions) An audio webcast of this call is available in the Investors section of Compugen's website, www.cgen.com. As a reminder, today's call is being recorded.

I would now like to introduce Elana Holzman, Compugen's Director of Investor Relations and Corporate Communications. Please go ahead.

Elana Holzman
Compugen Ltd. - Director of IR & Corporate Communications

Thank you, operator, and thank you for joining us today. With me from Compugen are Dr. Anat Cohen-Dayag, President and CEO; Dr. Henry Adewoye, Chief Medical Officer; Ari Krashin, CFO and COO; and Dr. Eran Ophir, VP Research and Drug Discovery. Anat will provide corporate highlights, after which Henry will review the data we disclosed earlier today, and Ari will review our financial statement and position. Anat, Henry, Ari and Eran will be available for the Q&A session.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot